Experimental fetal fluid therapy aims to save babies born without kidneys

NCT ID NCT03101891

First seen Jun 25, 2026 · Last updated Jul 01, 2026 · Updated 2 times

Summary

This trial tests whether repeatedly adding sterile fluid into the womb can help fetuses with severe kidney failure grow enough lungs to survive after birth. Pregnant women with early pregnancy kidney failure can choose to receive the infusions or just be monitored. Babies who survive will need intensive care, dialysis, and eventually a kidney transplant. The study is no longer enrolling for one type of kidney problem but continues for others.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

serial amnioinfusions with isotonic fluid

What this could lead to

If it works, this could help babies with severe kidney failure survive birth by improving lung growth, though they will still need lifelong dialysis and a kidney transplant.

What could go wrong

This is an early phase 1 trial with only 70 participants and no random assignment. There is a high risk of early rupture of membranes and premature delivery. The treatment does not fix the kidneys.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOWER URINARY TRACT OBSTRUCTIVE SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bilateral renal agenesis congenital anomalies of kidney and urinary tract 2 congenital anomaly of kidney and urinary tract Hereditary renal agenesis kidney failure lower urinary tract obstruction, congenital multicystic dysplastic kidney Multicystic renal dysplasia, bilateral Potter sequence pulmonary hypoplasia urinary tract obstruction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania, 19104, United States

  • Columbia University

    New York, New York, 10032, United States

  • Johns Hopkins Hospital

    Baltimore, Maryland, 21287, United States

  • Mayo Clinic

    Rochester, Minnesota, 55902, United States

  • Stanford University

    Stanford, California, 94305, United States

  • University of California San Francisco

    San Francisco, California, 94158, United States

  • University of Colorado Denver

    Aurora, Colorado, 80045, United States

  • University of Southern California/Children's Hospital of Los Angeles/Huntington Hospital

    Los Angeles, California, 90033, United States

  • University of Texas Health Science Center at Houston

    Houston, Texas, 77030, United States